Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systemic adjuvant therapy for high-risk cutaneous melanoma
Iyad Kobeissi, Ahmad A. Tarhini
Therapeutic Advances in Medical Oncology (2022) Vol. 14
Open Access | Times Cited: 14

Showing 14 citing articles:

Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells
Youssef Al Hmada, Robert T. Brodell, Naji Kharouf, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 470-470
Open Access | Times Cited: 16
BRAF V600-Mutated Metastatic Melanoma and Targeted Therapy Resistance: An Update of the Current Knowledge
Laetitia Florent, Charles Saby, Florian Slimano, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2607-2607
Open Access | Times Cited: 20
Perioperative therapy of melanoma: Adjuvant or neoadjuvant treatment
Piotr Rutkowski, Mario Mandalà
European Journal of Surgical Oncology (2024) Vol. 50, Iss. 3, pp. 107969-107969
Closed Access | Times Cited: 3
The Impact of Clinical and Histopathological Factors on Disease Progression and Survival in Thick Cutaneous Melanomas
Dana Antonia Țăpoi, Diana Derewicz, Ancuța-Augustina Gheorghișan-Gălățeanu, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2616-2616
Open Access | Times Cited: 7
A MEK inhibitor arrests the cell cycle of human conjunctival fibroblasts and improves the outcome of glaucoma filtration surgery
Jin‐Hee Lee, Megumi Honjo, Makoto Aihara
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Adjuvant Therapy for High-Risk Melanoma: An In-Depth Examination of the State of the Field
Islam Eljilany, Ella Castellano, Ahmad A. Tarhini
Cancers (2023) Vol. 15, Iss. 16, pp. 4125-4125
Open Access | Times Cited: 6
Guillain-Barre Syndrome due to Adjuvant Therapy with Dabrafenib Plus Trametinib
Aslı Geçgel, Sercan Ön, Yeliz Çiftçi, et al.
Balkan Medical Journal (2024)
Open Access | Times Cited: 1
Preferences of German and Swiss melanoma patients for toxicities versus melanoma recurrence during adjuvant treatment (GERMELATOX-A-trial)
Katharina C. Kähler, Svea Hüning, D. Nashan, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 13, pp. 11705-11718
Open Access | Times Cited: 2
Retrospective-Prospective Observational Study of Italian Patients Treated in Melanoma Adjuvant Cohort MAP–MADAM (Maximing ADjuvAnt MAP): Interim Analysis
Francesca Consoli, Marco Tucci, Jacopo Pigozzo, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 4072-4072
Open Access
Preferences of physicians for treatment-related toxicity vs. recurrence in melanoma (GERMELATOX-A): the doctors’ perspective
Katharina C. Kähler, Ralf Gutzmer, Yenny Angela, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 5
Open Access
Local intralesional talimogene laherparepvec therapy with complete local response in oral palatine mucosal melanoma: a case report
Saurabh Deepak Chitnis, Nolan B. Seim, Kari Kendra
Journal of Medical Case Reports (2024) Vol. 18, Iss. 1
Open Access
lnsights into Adjuvant Systemic Treatment Selection for Patients with Stage III Melanoma: Data from the Dutch Cancer Registry
Loeki Aldenhoven, Merel A. Spiekerman van Weezelenburg, Franchette W.P.J. van den Berkmortel, et al.
Targeted Oncology (2024) Vol. 19, Iss. 5, pp. 735-745
Open Access
Adjuvant Immunotherapy in Older Patients with Stage III and Resected Stage IV Melanoma: Toxicity and Recurrence-Free Survival Outcomes from the Dutch Melanoma Treatment Registry
A. Özkan, Ellen Kapiteijn, Frederiek van den Bos, et al.
European Journal of Cancer (2024) Vol. 212, pp. 115056-115056
Open Access
Preferences of melanoma patients to accept adjuvant therapy and toxicity – a qualitative substudy of the GerMelaTox-A project
Toni Maria Janke, Laura Moysig, Christine Blome, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 151, Iss. 1
Open Access
Page 1

Scroll to top